Dr. Mary Emily E. Sheffield, MD

Dr. Sheffield practices at Russell Medical in Alexander City, Alabama, part of University of Alabama at Birmingham.

Dr. Sheffield's NPI, 1811100050, was assigned on May 7, 2007. Dr. Sheffield graduated from University of Alabama School of Medicine in 2010. Dr. Sheffield holds Alabama license 27144.

Dr. Sheffield's primary practice is Russell Medical, at 3316 Highway 280, Alexander City, AL 35010 in Tallapoosa County. The practice phone is (256) 329-7100.

Dr. Sheffield's primary practice is Russell Medical in Alexander City, Alabama, part of University of Alabama at Birmingham. Dr. Sheffield is also affiliated with East Alabama Medical Center. The medical group on file is Russell Medical. Dmand AI also links Dr. Sheffield to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheffield practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sheffield's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sheffield is licensed in Alabama.

CMS data shows 856 Medicare services from Dr. Sheffield across 6 procedure codes in 2024, for 236 Medicare patients. Medicare paid $37,649 for them.

CMS counts 236 Medicare patients who saw Dr. Sheffield in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheffield's median patient age at 74, with 61% women.

In 2024, Dr. Sheffield wrote 1,375 Medicare Part D claims for 199 patients. 79% of them were for generic drugs. CMS names the drug for 1,196 of them, across 39 drugs with 11 or more claims each, at $3,850,405 in total drug cost. In 2023, CMS named 1,129 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Sheffield for performance year 2024, reported as part of a group. Dr. Sheffield accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 169 general payments to Dr. Sheffield from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $359.

Dr. Sheffield graduated from University of Alabama School of Medicine in 2010.